TEOSYAL® RHA3

Product Overview: TEOSYAL® RHA 3

TEOSYAL® RHA 3 is a sterile, non-pyrogenic, transparent viscoelastic gel based on resilient hyaluronic acid (RHA) technology. It combines cross-linked and non-modified HA of non-animal origin with 0.3% lidocaine hydrochloride for improved patient comfort. Produced by Teoxane Laboratories (Geneva, Switzerland), RHA 3 is engineered using a patented process designed to maintain the intrinsic properties of hyaluronic acid chains. This enables the gel to integrate within dynamic facial areas, providing correction while accommodating natural movement.

This formulation is specifically indicated for filling deep facial wrinkles and folds, such as severe nasolabial folds and marionette lines. It can also be used for cheek augmentation and restoring facial contours.

Note: Administration of TEOSYAL® RHA 3 is restricted to licensed medical professionals adequately trained in techniques for injecting dermal fillers.

Mechanism of Action and Properties

Leveraging Resilient Hyaluronic Acid (RHA) technology, TEOSYAL® RHA 3 possesses specific viscoelastic properties suited for deeper tissue integration and volume restoration in mobile facial areas. The gel structure is designed to withstand the mechanical stresses of facial expressions, providing durable support while maintaining a natural feel. Upon injection into the deep dermis or subcutaneous tissue (depending on indication), the hyaluronic acid component augments volume, smooths deep wrinkles, and enhances hydration by binding water molecules.

The inclusion of 0.3% lidocaine hydrochloride provides local anesthesia, significantly reducing patient discomfort during and immediately after the procedure.

While individual results vary based on patient characteristics, treatment area, and injection technique, the effects of TEOSYAL® RHA 3 typically last for several months.

Indications and Usage

TEOSYAL® RHA 3 is indicated for the correction of deep facial wrinkles, folds, and volume deficits, particularly in dynamic zones. Common applications include:

• Deep nasolabial folds
• Deep marionette lines
• Cheek augmentation
• Restoration of facial contours
• Filling vertical lip lines (smoker’s lines)
• Potential use for lip augmentation (subject to practitioner assessment and technique)

Injection should be performed into the deep dermis or appropriate subcutaneous plane by qualified practitioners following established protocols and aseptic techniques.

Expected Outcomes

Professional application of TEOSYAL® RHA 3 aims to provide:

• Significant reduction of deep wrinkles and folds
• Restoration and enhancement of facial volume
• Maintenance of natural facial dynamism and expression
• Improvement in skin firmness and texture in the treated region

Potential Adverse Events

Practitioners must discuss potential injection-related side effects with patients prior to treatment. Possible adverse events include:

• Common Reactions (Typically Transient): Injection site redness (erythema), swelling, bruising, pain, tenderness, itching, formation of palpable papules or nodules. These generally resolve within a week.
• Less Common/Rare but Serious Reactions: Persistent discoloration, induration (firmness), inflammation, infection, allergic/hypersensitivity responses, granuloma formation, abscesses, skin necrosis (rare), vascular complications including embolism (rare but potentially severe).

Comprehensive knowledge of potential complications and their management is essential. Patients must be advised to report any unusual, severe, or persistent reactions immediately.

Storage Conditions

Store between 2°C and 25°C. Avoid freezing and exposure to direct sunlight. Verify package integrity before use.

Disclaimer: This overview is not a substitute for the full product guidlines. Medical professionals must read and understand the complete product guidelines accompanying TEOSYAL® RHA 3, including all contraindications, warnings, precautions, and potential adverse reactions, prior to product administration.